Oxidative stress: a new risk factor for thyroid cancer

BRAFV600E and Microenvironment in Thyroid Cancer: A Functional Link to Drive Cancer Progression

(2011) C. Nucera et al.   CANCER RESEARCH

Total oxidant/antioxidant status in sera of patients with thyroid cancers

(2011) Dong Wang et al.   ENDOCRINE-RELATED CANCER

Progression of BRAF-induced thyroid cancer is associated with epithelial–mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

(2011) J A Knauf et al.   ONCOGENE

A Comparative Study of the Oxidative Profile in Graves’ Disease, Hashimoto’s Thyroiditis, and Papillary Thyroid Cancer

(2010) Saloua Lassoued et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

B-RafV600E and thrombospondin-1 promote thyroid cancer progression

(2010) C. Nucera et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer

(2010) Mingzhao Xing   THYROID

The BRAFV600E Oncogene Induces Transforming Growth Factor   Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer

(2009) G. Riesco-Eizaguirre et al.   CANCER RESEARCH

Role of NF-κB in thyroid cancer

(2009) Francesco Pacifico et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Oxidant/antioxidant balance in patients with thyroid cancer

(2008) Melih Akinci et al.   Acta Cirurgica Brasileira

Oxidative Stress Plays a Critical Role in Inactivating Mutant BRAF by Geldanamycin Derivatives

(2008) Y. Fukuyo et al.   CANCER RESEARCH

The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status

(2008) Hüsamettin Erdamar et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism

(2008) Ayse Nur Torun et al.   CLINICAL ENDOCRINOLOGY

Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension

(2008) Megan R. Haymart et al.   CLINICAL ENDOCRINOLOGY

Potent Inhibition of Thyroid Cancer Cells by the MEK Inhibitor PD0325901 and Its Potentiation by Suppression of the PI3K and NF-κB Pathways

(2008) Dingxie Liu et al.   THYROID